http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2519090-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c229187936ebd346db01e595b7b2ab7c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-02 |
| filingDate | 2009-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bc3b0d59b55fd96a832d9983b492ce9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3997521094fb6dfe9611da65ef2651da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_450c9bc5fe299813a5c1e42149c5ad33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8b80dd9af7c0d4f3584a6f49d929328 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5945b5c78089baa9672804c35801cb3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93e8d44480ac02dd855113c887d84962 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2169939f270a998e95514615ee45985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d6d8f4d89505bddb93dd12bb7fdfea3 |
| publicationDate | 2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2519090-T3 |
| titleOfInvention | Phenyl piperazine compounds, pharmaceutical composition that includes them, and use thereof |
| abstract | A piperazine compound represented by formula (I): ** Formula ** or pharmaceutically acceptable salts thereof, wherein n is an integer from 2 to 6; R1 and R2 are the same or different and are independently selected from the group consisting of hydrogen, a hydroxyl group, a halogen, nitrogen dioxide, a straight or branched chain alkyl group having 1 to 4 carbon atoms, and a group straight or branched chain alkoxy with 1 to 4 carbon atoms; R3 is a C1-C2 alkylene; and R4 is selected from the group consisting of: (a) a C2-C6 dialkylamine, (b) a 5- to 9-membered aromatic amine in which the ring is independently substituted with at least one hydrogen, an alkyl C1-C6 aliphatic, a C3 to C10 cyclic alkyl, a C6-C10 aryl group and a halogen, (c) a 5- to 9-membered heteroaromatic amine comprising at least one nitrogen atom as a ring constituent in which the ring is independently substituted by at least one hydrogen, a C1-C6 aliphatic alkyl, a C3 to C10 cyclic alkyl, a C6-C10 aryl group and a halogen, (d) a heterocyclic ring consisting of 5 to 9 members comprising at least one nitrogen atom as a constituent of the ring in which the ring is independently substituted with at least one of hydrogen, a C1-C6 aliphatic alkyl, a C3 to C10 cyclic alkyl, a C6-C10 aryl group and a halogen, and (e) an interoaromatic ring integ 5 to 9 membered radical comprising at least one nitrogen atom as a constituent of the ring in which the ring is independently replaced with at least one of hydrogen, a C1-C6 aliphatic alkyl, a C3 to C10 cyclic alkyl, a C6-C10 aryl group and a halogen; and R4 is connected to group R3 through a nitrogen atom therein. |
| priorityDate | 2008-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 275.